About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet ...

According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

Introduction While robotic prostatectomies are gaining popularity, laparoscopic and open surgeries remain prevalent in Central and Eastern Europe due to cost-effectiveness. In Poland, many urology ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

With the advent of robotic surgery and its use during radical prostatectomy, surgeons have been able to better identify those tissue planes secondary to the improved magnified 10 × 3D vision.

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Glenn Bauman discussing a prospective provincial registry of PSMA PET/CT for recurrent prostate cancer. While most ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Brent Streit's journey included countless, often painful, milestones, including complications, further surgeries, therapies and more.